Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;123(10):4131-3.
doi: 10.1172/JCI70430. Epub 2013 Oct 1.

P-glycoprotein ABCB1: a major player in drug handling by mammals

P-glycoprotein ABCB1: a major player in drug handling by mammals

Piet Borst et al. J Clin Invest. 2013 Oct.

Abstract

Mammalian P-glycoproteins are active drug efflux transporters located in the plasma membrane. In the early nineties, we generated knockouts of the three P-glycoprotein genes of mice, the Mdr1a, Mdr1b, and Mdr2 P-glycoproteins, now known as Abcb1a, Abcb1b, and Abcb4, respectively. In the JCI papers that are the subject of this Hindsight, we showed that loss of Mdr1a (Abcb1a) had a profound effect on the tissue distribution and especially the brain accumulation of a range of drugs frequently used in humans, including dexamethasone, digoxin, cyclosporin A, ondansetron, domperidone, and loperamide. All drugs were shown to be excellent substrates of the murine ABCB1A P-glycoprotein and its human counterpart, the MDR1 P-glycoprotein, ABCB1. We found that the ability of ABCB1 to prevent accumulation of some drugs in the brain is a prerequisite for their clinical use, as absence of the transporter led to severe toxicity or undesired CNS pharmacodynamic effects. Subsequent work has fully confirmed the profound effect of the drug-transporting ABCB1 P-glycoprotein on the pharmacokinetics of drugs in humans. In fact, every new drug is now screened for transport by ABCB1, as this limits oral availability and penetration into sanctuaries protected by ABCB1, such as the brain.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of ABCB1 functional expression throughout the body.
Blue lines indicate the location of ABCB1. Small arrows indicate the direction of ABCB1-mediated transport. Bold green arrows indicate net body excretion of ABCB1 substrates. ABCB1 in the BBB and blood-testis and placental fetal-maternal barrier protects brain, testis, and fetus, respectively, from accumulation of ABCB1 substrates. ABCB1 in small and large intestine reduces intestinal uptake (oral availability) and mediates direct intestinal excretion of substrates. ABCB1 in liver and kidney mediates hepatobiliary and renal excretion of substrates. ABCB1 expression in tumor cells can contribute to multidrug resistance.

References

    1. Te Riele H, Robanus-Maandag EC, Berns A. Highly efficient gene targeting in embryonic stem cells via homologous recombination with isogenic DNA constructs. Proc Natl Acad Sci U S A. 1992;89(11):5128–5132. doi: 10.1073/pnas.89.11.5128. - DOI - PMC - PubMed
    1. Schinkel AH, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. . Cell. 1994;77(4):491–502. doi: 10.1016/0092-8674(94)90212-7. - DOI - PubMed
    1. Schinkel AH, Wagenaar E, Van Deemter L, Mol CAAM, Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest. 1995;96(4):1698–1705. doi: 10.1172/JCI118214. - DOI - PMC - PubMed
    1. Schinkel AH, Wagenaar E, Mol CAAM, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996;97(11):2517–2524. doi: 10.1172/JCI118699. - DOI - PMC - PubMed
    1. Mayer U, et al. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein. Br J Pharmacol. 1996;119(5):1038–1044. doi: 10.1111/j.1476-5381.1996.tb15775.x. - DOI - PMC - PubMed

Publication types

Substances